Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.
Also called NCT06046196
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 148 participants
- Sponsor
- Registry
-
NCT06046196
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT06046196. Randomized; no masking; primary purpose treatment. Start 2020-11-18 (actual); primary completion 2023-03-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease
- Condition
- Arterial Occlusive Diseases
- Condition
- Intermittent Claudication
- Intervention (Drug)
- Sarpogrelate SR
- Intervention (Drug)
- Sarpogrelate
- Lead sponsor
- Yuhan Corporation
Record details
- Record id
cardio:ct-nct06046196- Content hash
c103e169b4a203fac4dd7e210feeab6e7dfb46955032af368f32fb5913d6c0a7